Abstract:BACKGROUND:The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the peak season of common respiratory viral infections. However, the clinical symptoms of most SARS-CoV-2 infected patients are not significantly different from those of common respiratory viral infections. Therefore, knowing the epidemiological patterns of common respiratory viruses may be valuable to improve the diagnostic and therapeutic efficacy of patients with suspected COVID-19, especially in Southwest China (a mild epidemic area).METHODS:A total of 2188 patients with clinically suspected of COVID-19 in Southwest China were recruited from January 21 to February 29, 2020. Nasopharyngeal swabs, throat swabs and sputum specimens were collected to detect SARS-CoV-2 by using real-time reverse transcription-polymerase chain reaction (RT-PCR) and other 12 viruses via PCR fragment analysis combined with capillary electrophoresis. Clinical characteristics and laboratory test findings were acquired from electronic medical records. All data were analyzed to unravel the epidemiological patterns.RESULTS:Only 1.1% (24/2188) patients with suspected COVID-19 were eventually confirmed to have SARS-CoV-2 infection, and the most frequently observed symptoms were fever (75.0%, 18/24) and cough (20.8%, 5/24). The overall detection rate of other respiratory pathogens was 10.3% (226/2188). Among them, human rhinovirus (3.2%, 71/2188), human parainfluenza viruses (1.6%, 35/2188), influenza B virus (1.2%, 26/2188) and mycoplasma pneumonia (1.2%, 26/2188) were the predominantly detected pathogens in this study. Moreover, the co-infection was observed in 22 specimens. Notably, one COVID-19 case had a coexisting infection with human parainfluenza virus (4.2%, 1/24) and bocavirus was the most common virus tending to occur in co-infection with other respiratory pathogens.CONCLUSIONS:This study reveals the epidemiological features of common respiratory viruses and their clinical impact during the ongoing outbreak of COVID-19 in a mild epidemic area. The findings highlight the importance of understanding the transmission patterns of the common respiratory virus in COVID-19 regions, which can provide information support for the development of appropriate treatment plans and health policies, while eliminating unnecessary fear and tension.

Isolation and Identification of Two Strains of Severe Acute Respiratory Syndrome Coronavirus 2 from Coronavirus Disease 2019 Patients in Shanghai

Phylogenic Analysis of SARS-Coronavirus Isolated from Zhejiang Province

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue

Analysis of Adjunctive Serological Detection to Nucleic Acid Test for Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection Diagnosis

Early Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies As A Serologic Marker Of Infection In Patients With Coronavirus Disease 2019

Temporal and Spatial Distribution of SARS-CoV-2 Aerosols in a Large-Scale Fangcang Shelter Hospital in Shanghai, China

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Lower Respiratory Tract Samples Are Reliable for Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Diagnosis and Animal Model Study

Viral and host factors related to the clinic outcome of the SARS CoV 2 infection

Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

Isolation and identification of etiological agent of COVID-19

Epidemiological Surveillance of Common Respiratory Viruses in Patients with Suspected COVID-19 in Southwest China.

Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

Laboratory Detection on Severe Acute Respiratory Syndrome

Isolation and Identification of a Rare Spike Gene Double-Deletion SARS-CoV-2 Variant From the Patient With High Cycle Threshold Value

Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China

Analysis and Validation of a Highly Sensitive One-Step Nested Quantitative Real-Time Polymerase Chain Reaction Assay for Specific Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Pathogenic analysis of suspected COVID-19 patients in a SARS-CoV-2 non-epidemic area of China

Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients